Advantest’s interim dividend rises to ¥49: Is cash flow keeping pace?

Advantest Corporation has raised its interim dividend to ¥49 a share for the six months ended 30 September 2026, from ¥29 for the comparable period a year earlier. That is an increase of about 69%. For dividend investors, the useful question is whether the stronger payout is supported by cash as well as reported profit. [S1, p. 1]

The company announced the half-year results on 28 October 2026 and listed 1 December 2026 as the planned dividend payment date. Its results table does not give a year-end dividend or a full-year dividend total for the current fiscal year, so the interim amount should not be read as an annual promise. [S1, p. 1]

Earnings grew, but one gain needs separating

Half-year sales rose to ¥845.2 billion from ¥526.7 billion, while operating income increased to ¥456.8 billion from ¥232.4 billion. Advantest attributed the stronger operating result partly to higher tester sales and an improved sales mix. The filing says demand for its systems grew as customers produced more complex AI-related semiconductors. [S1, p. 1] [S1, p. 4]

Net income attributable to owners of the parent reached ¥368.1 billion, up from ¥169.8 billion. That increase includes help from a ¥54.2 billion valuation gain on financial instruments related to strategic investments, recorded within financial income. The gain matters when judging how repeatable the profit growth might be; it is separate from the improvement in operating income. [S1, p. 1] [S1, p. 10] [S1, p. 15]

The cash test

Operating cash flow was ¥307.0 billion for the half-year, compared with ¥139.9 billion a year earlier. After the ¥21.5 billion spent on property, plant and equipment and ¥1.2 billion on intangible assets, approximately ¥284.3 billion remained. This is a measure of cash after those two types of capital spending, not a forecast of cash available for future dividends. [S1, p. 13]

There is a constraint to watch: inventories absorbed ¥119.5 billion of cash during the period. Higher trade payables and advance receipts helped offset that use of cash. The cash-flow statement also removes the investment valuation gain when reconciling profit to operating cash flow, so the stronger operating cash figure does not simply reflect that gain. [S1, p. 13]

Other cash uses deserve separate treatment. Advantest spent ¥184.4 billion buying debt instruments, an investing cash flow that is distinct from the equipment and intangible spending above. It also spent ¥105.9 billion repurchasing shares, while receiving ¥100.0 billion from issuing convertible bonds with stock acquisition rights. Those choices affect liquidity and the share base, even though they do not change the stated ¥49 interim dividend per share. [S1, p. 13]

What the increase says—and what it does not

Advantest lifted its full-year net income forecast to ¥741.5 billion from ¥660.0 billion in July. That gives context for the higher interim dividend, but the forecast is still an estimate and the filing supplies no full-year dividend figure. Its half-year statements are exempt from an auditor review, another reason to watch the next results and dividend announcement rather than extend the interim increase mechanically into the second half. [S1, p. 7] [S1, p. 1] [S1, p. 2]

For now, the dividend increase is backed by a substantial improvement in operating cash flow. The next test is whether cash generation remains strong as inventories grow, and what Advantest subsequently says about its year-end payout. [S1, p. 13] [S1, p. 1]